Skip to main content
UCL Ventures Navigate back to homepage
Find your Business Manager

Main navigation

  • Your route to market

    Your route to market

    We guide UCL academics, researchers and clinicians to get their research to market.

    Disclose an idea
    • Getting started An introduction to commercialisation and next steps
    • Our collaborative approach How we work with you to get to market
    • What you can expect Demystifying the process of commercialisation
    • Options to move forwards Explore the different pathways to market
      • Protect your idea
      • Create a company
      • Licensing your invention
      • Routes to social impact
    • Funding & support The financial and practical help that we can offer
      • Help managing your project
      • Training & tools
      • Common questions
  • Explore innovations

    Explore innovations

    Our portfolio and technologies span AI and quantum, to gene therapies to consumer products.

    • Spinout portfolio Browse our portfolio of spinout companies, based on UCL research
    • Our expertise & pipeline The sectors we span and therapeutics in development
    • Social Ventures Ventures driving impact in communities
    • License a technology Opportunities & collaborations with UCL's world-class research
  • Global impact

    Global impact

    How UCL research is changing the way the world lives, works and thrives.

    • Inspiring stories Real-world impact and successes, supported by UCL Ventures
    • Impact Report Our annual report showcases how UCL research is going beyond the university
    • Supporting innovation at UCL Understand our role in the innovation ecosystem
  • Investors & business

    Investors & business

    Opportunities for collaboration across UCL's world-class research

    • Why partner with UCL Ventures With over 30 years in commercialisation, we have a strong track record
    • Our portfolio View our spinout companies across all sectors
  • News & events

    News & events

    The latest news and events from our team and portfolio

    • Current page: News & views Stay up to date with the latest insights and announcements
    • Events Where you can find us across UCL and external events
  • Get in touch

    Get in touch

    Contact our team of experts for all your queries and needs

    • Speak to the team Choose your enquiry type to reach the right team
Find your Business Manager

I-O Inspire entrepreneurs shine at finale showcase

With just three minutes and four slides each, participants pitched their ideas to an audience of venture capitalists, academics, and innovation professionals.

25 June 2025

Breadcrumb trail

  1. Home
  2. News & events
  3. News & views
  4. I-O Inspire entrepreneurs shine at finale showcase

Hosted at UCL’s BaseKX incubator in London, the event brought together the latest cohort of budding academic entrepreneurs supported by UCL Ventures' Ideas to Opportunities (I-O) programme.  

The evening featured a dynamic mix of innovation, from next-generation battery technologies and audiology breakthroughs with applications in robotics and hearing aids, to miniaturised satellite communication components and new insights into how the human body defends its respiratory system from infection. 

The researchers’ pitches* were evaluated by a panel that included UCL Ventures' Associate Director (Physical Sciences & Engineering) Marina Santilli, UCL Ventures Associate Director BioPharm Mark Fisher, and I&E’s Ecosystem Innovation, Graca Carvalho, CDI Executive Director, UCL, and Growth Specialist Emilio Cuevas.  

The event marked the finale of UCL Ventures’ I-O Inspire programme, an 8-week series of lectures and seminars aimed at growing the entrepreneurial skills of UCL academics and supporting them to take the next steps in commercialising their research.  

I-O Inspire is just one element of the I-O programme: join UCL Ventures for the next in the ongoing I-O Converse session on 2nd July, 12.30-2pm to hear about UCL spinout Guilford Street Labs (GSL)’s mission to elevate care for patients with rare, cardiac and neurodegenerative diseases.   

*Pitches featured: Max Woodall , cylindAIR: A 3D Human Airway Model for the Next Generation of Respiratory Therapeutics; Farah Comis, Integrated photonics for Data Centers; Janos Kriston-Vizi, AI Model for Cellular Drug Discovery; Charlie Nason & Yang Xu, Next-generation cathode materials for low cost potassium-ion batteries; Wenhui Song, Intelligent Hearing Aids – Ihear; Paul Bavister, Wearable AI therapy / sound attenuation; Robert Bolt, Mechanochemistry; Amany Kassem, Nibras Communication- Pioneering optical-assisted transceiver to unlock terabit-scale wireless data transfer; Niyaz Zaman, ULK-1 TArgeting Chimeras (ULKTACs): A Transformative Step in Targeted Degradation; Yaoguang Song, Unlocking Next-Gen Batteries through Scalable Interface Engineering.

UCL Ventures footer

About UCL Ventures

  • Our people
  • What we do
  • Who we are
  • Our culture

Forms & Resources

  • Publications and downloads

Accreditations

  • Cyber essentials
    cyber essentials logo
  • Living wage
    living wage employer logo
UCL Ventures

UCL Ventures Limited (Company Registration No: 02776963) is a wholly-owned subsidiary of University College London. 

Registered office: 
University College London
Gower Street
London
WC1E 6BT

UCL social media menu

  • Link to Linkedin
Back to top

Legal

  • Cookie policy
  • Freedom of information
  • Privacy policy
  • Rules of website use

© 2026 UCL Business Ltd